The Cooper Companies, Inc. $COO Shares Bought by Avalon Trust Co

Avalon Trust Co lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 207,030 shares of the medical device company’s stock after buying an additional 3,070 shares during the quarter. Cooper Companies makes up 1.1% of Avalon Trust Co’s investment portfolio, making the stock its 24th largest position. Avalon Trust Co owned about 0.10% of Cooper Companies worth $14,732,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Zions Bancorporation National Association UT acquired a new stake in Cooper Companies during the 1st quarter worth approximately $33,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies during the first quarter worth approximately $40,000. J.Safra Asset Management Corp raised its stake in shares of Cooper Companies by 204.8% in the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares in the last quarter. Assetmark Inc. raised its position in shares of Cooper Companies by 357.8% during the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after acquiring an additional 483 shares in the last quarter. Finally, Larson Financial Group LLC boosted its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after buying an additional 664 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on COO shares. Barclays assumed coverage on Cooper Companies in a research note on Monday, October 13th. They issued an “overweight” rating and a $85.00 target price on the stock. BNP Paribas raised Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. The Goldman Sachs Group set a $64.00 target price on Cooper Companies and gave the stock a “sell” rating in a report on Wednesday, October 1st. Robert W. Baird reduced their price target on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a research report on Thursday, August 28th. Finally, Wells Fargo & Company dropped their target price on Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $84.77.

Insider Transactions at Cooper Companies

In related news, COO Gerard H. Warner III purchased 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Brian G. Andrews acquired 1,525 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The stock was purchased at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the completion of the transaction, the executive vice president directly owned 22,191 shares in the company, valued at approximately $1,457,504.88. The trade was a 7.38% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 17,975 shares of company stock valued at $1,216,346. 1.98% of the stock is owned by insiders.

Cooper Companies Trading Up 1.0%

Shares of COO stock opened at $72.49 on Thursday. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $106.63. The firm has a market capitalization of $14.41 billion, a P/E ratio of 35.71, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The firm’s fifty day simple moving average is $69.54 and its 200 day simple moving average is $72.44. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies declared that its Board of Directors has authorized a stock repurchase program on Wednesday, September 17th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s leadership believes its shares are undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.